The Latest Cardiac and Vascular News
Malmö August 5, 2019 CADScor®System – Significantly more effective than current practice Acarix AB (publ) (ACARIX: FN Stockholm) today announced the publication of a meta-analysis including 2245 patients showing Acarix’s leading CADScor®System is more than three times as effective as current practice, implying clinical and economic advantages. “Strong clinical evidence is one of the key […]
Malmö June 27, 2019 Acarix CADScor®System included in NICE guidelines (UK) Acarix AB (publ) (ACARIX: FN Stockholm) today announced that the CADScor®System has been included as a first line investigation for ruling out suspected stable Coronary Artery Disease by the British National Institute for Health and Care Excellence (NICE). The CADScor®System was included in the […]
